PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 3:52 AM ET

Sponsor Check › Person

CS

Christy Shaffer

Named as an officer, director or promoter on SEC Form D filings · NC, MD, CA, GA · Nov 23, 2009 → Oct 14, 2026

18deals (issuers)
$673.1Mreported sold
466investors
53Form D filings
2009–2026years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:20 AM ET · SEC enforcement last checked: not yet

The short version

Christy Shaffer is listed as an executive officer, director, and promoter on 53 SEC Form D filings by 18 issuers between Nov 2009 and Oct 2026. Largest by amount reported sold: Hatteras Venture Partners VI, LP (Durham, NC — pooled investment fund — 2019–2020; $137.3M reported sold to 64 investors), Hatteras Venture Partners VII, LP (Durham, NC — pooled investment fund — 2023; $135.1M reported sold to 88 investors), Hatteras Venture Partners V, LP (Durham, NC — pooled investment fund — 2015; $91.1M reported sold to 34 investors), CalciMedica, Inc. (La Jolla, CA — biotechnology — 2015–2018; $75.4M reported sold to 55 investors), G1 Therapeutics, Inc. (Research Triangle Park, NC — biotechnology — 2013–2016; $50M reported sold to 21 investors) and 13 more (all listed below).

What this means That is a lot of deals — 18 separate companies raised money with this person listed as executive officer, director, and promoter, over about 17 years. Across those companies the filings report $673.1M sold in total.

Listed alongside Clay Thorp (21 shared filings), John Crumpler (13 shared filings), Douglas Reed (10 shared filings), Michael Dial (8 shared filings), Daniel H. White (6 shared filings) and 89 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Christy. Each name links to their own page.

The issuers belong to 2 sponsor groups: Hatteras Venture (9 issuers, $512.7M reported sold, 2011–2026) and Valence (5 issuers, $90.8M reported sold, 2009–2023).

What this means This person is listed across more than one sponsor team; each group page shows that team's full track record.

Public records searched: federal courts (CourtListener / RECAP), state securities regulators (AZ, CA, DE, TX, WA) — 1 SEC release, 3 bankruptcy cases matching the name listed in Key records below. Not yet searched: SEC enforcement releases.

What this means 4 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

What the community is saying

Nothing found on Reddit, BiggerPockets or community forums for high-net-worth investors (searched Oct 24, 2026) — search queued; this line updates when it has run.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts; live RECAP re-check pending. State courts: not yet searched. PACER: not searched. · Last checked Oct 24, 2026, 2:20 AM ET.

State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

1 SEC release

Inspire Pharmaceuticals, Inc., Christy L. Shaffer, and Mary B. Bennett Administrative proceeding
SEC · Sep 30, 2008 · Parties as named in the release: Inspire Pharmaceuticals, Inc., Christy L. Shaffer, and Mary B. Bennett Read the release ↗
same full name in the release title; the person's filing state is named in the release
What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — matched Oct 23, 2026, 9:12 PM ET from the sec.gov index; a name search for this subject has not completed yet.

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states: not yet searched.

No SEC search has run yet for this person.

3. Bankruptcies

3 cases: 3 closed (disposition not in docket feed)

Matthew B. Shaffer and Christy T. Shaffer closed
United States Bankruptcy Court, N.D. Indiana · No. 13-12295 · Filed Jul 30, 2013 · Closed Dec 19, 2013
Role of Christy T. Shaffer: Debtor · Outcome: Case closed 2013-12-19 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 8 federal dockets); court in IN (not a filing state)
Ottis Shaffer and Christy Shaffer closed
United States Bankruptcy Court, N.D. Mississippi · No. 04-12299 · Filed Apr 12, 2004 · Closed Aug 20, 2004
Role of Christy Shaffer: Debtor · Outcome: Case closed 2004-08-20 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 8 federal dockets); court in MS (not a filing state)
Gary J. Shaffer and Christy L. Shaffer closed
United States Bankruptcy Court, W.D. New York · No. 1-94-10762 · Filed Mar 18, 1994 · Closed Jul 27, 1994
Role of Christy L. Shaffer: Debtor · Outcome: Case closed 1994-07-27 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 8 federal dockets); court in NY (not a filing state)
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:20 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Not made for individual people — comparisons cover issuers and sponsor groups

5. Money to insiders

0 of 41 offerings report sales commissions; 1 reports finder's fees totalling $118,000; 6 report proceeds to related persons totalling $2,535,000. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Oct 14, 2026 D
Hatteras Opportunity Fund II, LP
File 021-601154
$0$0$0
Other than the payment of management fees, salaries and other compensation and benefits, no partner, officer, director, manager or promoter will receive any payments from the proceeds of this offering.
None listed on this filingEDGAR ↗
Aug 19, 2026 D
Aer Therapeutics, Inc.
File 021-594730
$0$0$0
Proceeds will be used for working capital, which may include normal compensation to executive officers.
None listed on this filingEDGAR ↗
Jul 20, 2026 D
Healthcare Innovations Venture Fund, LLC
File 021-591483
$0$0$0
Other than the payment of management fees, salaries and other compensation and benefits, no partner, officer, director, manager or promoter will receive any payments from the proceeds of this offering.
None listed on this filingEDGAR ↗
Apr 13, 2026 D
Hatteras CREATE SF SPV, LLC
File 021-580086
$0$0$0
Other than reimbursement of expenses, no officer, director, partner, manager or promoter will receive any payments from the proceeds of this offering
None listed on this filingEDGAR ↗
May 7, 2025 D
Trefoil Therapeutics, Inc.
File 021-545445
$0$0$0None listed on this filingEDGAR ↗
Feb 7, 2025 D
Aer Therapeutics, Inc.
File 021-537674
$0$0$0
Proceeds will be used for working capital, which may include normal compensation to executive officers.
None listed on this filingEDGAR ↗
Mar 7, 2024 D/A
Hatteras Opportunity Fund I, LP
File 021-472491
$0$0$0
Other than the payment of management fees, salaries and other compensation and benefits, no partner, officer, director, manager, or promoter will receive any payments from the proceeds of this offering.
None listed on this filingEDGAR ↗
Sep 8, 2023 D/A
Hatteras Venture Partners VII, LP
File 021-472476
$0$0$0
Other than the payment of management fees, salaries and other compensation and benefits, no partner, officer, director, manager or promoter will receive any payments from the proceeds of this offering.
None listed on this filingEDGAR ↗
Dec 22, 2022 D
Aer Therapeutics, Inc.
File 021-468459
$0$0$0 (est.)
Proceeds will be used for working capital, which may include normal compensation to executive officers.
None listed on this filingEDGAR ↗
Jun 15, 2022 D/A
PIPr Therapeutics, Inc.
File 021-384210
$0$0$0
No amounts other than ordinary course employment compensation is being paid to officers and directors.
None listed on this filingEDGAR ↗
Mar 22, 2022 D
Trefoil Therapeutics, Inc.
File 021-438338
$0$0$0None listed on this filingEDGAR ↗
Oct 15, 2020 D/A
Hatteras Venture Partners VI, LP
File 021-337301
$0$0$0
Other than the payment of management fees, and other compensation and benefits no partner, manager or promoter will receive any payments from the proceeds of this offering.
None listed on this filingEDGAR ↗
Jul 29, 2020 D
Perfuse Therapeutics, Inc.
File 021-372028
$0$0$0None listed on this filingEDGAR ↗
Mar 4, 2020 D
PIPr Therapeutics, Inc.
File 021-361935
$0$0$0
No amounts other than ordinary course employment compensation is being paid to officers and directors.
None listed on this filingEDGAR ↗
Dec 4, 2019 D
Clearside Biomedical, Inc.
File 021-354771
$0$0$0None listed on this filingEDGAR ↗
Aug 5, 2019 D/A
Trefoil Therapeutics, Inc.
File 021-344522
$0$0$0None listed on this filingEDGAR ↗
Apr 4, 2019 D
Perfuse Therapeutics, Inc.
File 021-336458
$0$0$0None listed on this filingEDGAR ↗
Mar 8, 2019 D
PIPr Therapeutics, Inc.
File 021-334395
$0$0$0
No amounts other than ordinary course employment compensation is being paid to officers and directors.
None listed on this filingEDGAR ↗
Oct 4, 2018 D
Spyryx Biosciences, Inc.
File 021-322834
$0$0$0
Proceeds will be used for working capital, which may include normal compensation to executive officers.
None listed on this filingEDGAR ↗
Jun 13, 2018 D/A
CalciMedica, Inc.
File 021-263150
$0$0$0None listed on this filingEDGAR ↗
Jul 12, 2017 D
Spyryx Biosciences, Inc.
File 021-290488
$0$0$0
Proceeds will be used for working capital, which may include normal compensation to executive officers.
None listed on this filingEDGAR ↗
Dec 8, 2016 D
Trefoil Therapeutics, Inc.
File 021-275923
$0$0$0None listed on this filingEDGAR ↗
Jul 1, 2016 D/A
G1 Therapeutics, Inc.
File 021-262918
$0$0$0None listed on this filingEDGAR ↗
Dec 21, 2015 D
CalciMedica, Inc.
File 021-253475
$0$0$35,000 (est.)
Consulting payments to certain officers.
None listed on this filingEDGAR ↗
Dec 8, 2015 D
Clearside Biomedical, Inc.
File 021-252601
$0$0$0
Proceeds will be used for working capital, which will include normal compensation to executive officers.
None listed on this filingEDGAR ↗
Dec 7, 2015 D
KinoDyn, Inc.
File 021-252561
$0$0$0
Other than the payment of salaries and other compensation benefits, no officer, director or promoter will receive any payments from the proceeds of this offering.
None listed on this filingEDGAR ↗
Aug 24, 2015 D
Hatteras Venture Partners V, LP
File 021-246318
$0$0$0
Other than the payment of salaries and other compensation and benefits, no officer, director, manager or promoter will receive any payments from the proceeds of this offering.
None listed on this filingEDGAR ↗
May 8, 2015 D
Spyryx Biosciences, Inc.
File 021-239432
$0$0$0
Proceeds will be used for working capital, which will include normal compensation to executive officers/managers.
None listed on this filingEDGAR ↗
Feb 12, 2015 D
G1 Therapeutics, Inc.
File 021-233991
$0$0$0
Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering.
None listed on this filingEDGAR ↗
Sep 15, 2014 D
Clearside Biomedical, Inc.
File 021-224726
$0$118,000$550,000 (est.)None listed on this filingEDGAR ↗
Jun 23, 2014 D/A
G1 Therapeutics, Inc.
File 021-204775
$0$0$0
Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering.
None listed on this filingEDGAR ↗
Jun 19, 2014 D
KinoDyn, Inc.
File 021-219470
$0$0$0
Excluding salaries paid in the ordinary course of business.
None listed on this filingEDGAR ↗
May 12, 2014 D
Clearside Biomedical, Inc.
File 021-217166
$0$0$450,000 (est.)None listed on this filingEDGAR ↗
Aug 23, 2013 D/A
G1 Therapeutics, Inc.
File 021-195183
$0$0$0
Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering.
None listed on this filingEDGAR ↗
Feb 12, 2013 D
Clearside Biomedical, Inc.
File 021-191713
$0$0$600,000 (est.)None listed on this filingEDGAR ↗
Apr 20, 2012 D/A
EVOAPP, INC.
File 021-168803
$0$0$0None listed on this filingEDGAR ↗
Feb 16, 2012 D/A
Clearside Biomedical, Inc.
File 021-171400
$0$0$500,000 (est.)None listed on this filingEDGAR ↗
May 10, 2011 D
Clinipace Inc
File 021-159540
$0$0$0None listed on this filingEDGAR ↗
May 9, 2011 D
Clinipace Inc
File 021-159422
$0$0$0None listed on this filingEDGAR ↗
Feb 11, 2011 D
EVOAPP, INC.
File 021-155251
$0$0$400,000
Normal and reasonable salaries as approved by the board of directors.
None listed on this filingEDGAR ↗
Nov 23, 2009 D
Clinipace Inc
File 021-80138
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 18

Every issuer that named Christy Shaffer on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

HO
Pooled Investment Fund · group: Hatteras Venture

Hatteras Opportunity Fund II, LP

Durham, NC · Oct 14, 2026
  • Oct 14, 2026 · D · $22,250,000 sold of $100,000,000 · 21 investors · min. No minimum reported · role: Executive Officer (Manager of Hatteras Venture Advisors VIII, LLC) EDGAR ↗

Raised $22.3M from 21 investors (22% of the $100M target) as of the latest filing. Christy is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

AT
Biotechnology

Aer Therapeutics, Inc.

Research Triangle Park, NC · Dec 22, 2022 → Aug 19, 2026 · 3 filings
  • Aug 19, 2026 · D · $3,000,000 sold of $3,000,000 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 7, 2025 · D · $5,000,000 sold of $5,000,000 · 15 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 22, 2022 · D · $15,882,384 sold of $36,882,384 · 23 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $15.9M from 23 investors (100% of the $3M target) as of the latest filing. Christy is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

HI
Pooled Investment Fund · group: Hatteras Venture

Healthcare Innovations Venture Fund, LLC

Durham, NC · Jul 20, 2026
  • Jul 20, 2026 · D · $25,000,000 sold of $125,000,000 · 2 investors · min. No minimum reported · role: Executive Officer (Manager of Hatteras Venture Advisors VI, LLC, Manager of the Issuer) EDGAR ↗

Raised $25M from 2 investors (20% of the $125M target) as of the latest filing. Christy is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

HC
Investing · group: Hatteras Venture

Hatteras CREATE SF SPV, LLC

Durham, NC · Apr 13, 2026
  • Apr 13, 2026 · D · $736,987 sold of $3,000,000 · 2 investors · min. No minimum reported · role: Executive Officer (Manager of Hatteras Venture Advisors VI, LLC, Manager of the Issuer) EDGAR ↗

Raised $737K from 2 investors (25% of the $3M target) as of the latest filing. Christy is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Investing / 506(b) (2,521 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

TT
Biotechnology

Trefoil Therapeutics, Inc.

El Cajon, CA · Dec 8, 2016 → May 7, 2025 · 5 filings
  • May 7, 2025 · D · $4,559,996 sold of $5,000,000 · 16 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 22, 2022 · D · $11,970,548 sold of $12,000,000 · 14 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 5, 2019 · D/A · $12,604,500 sold of $28,010,000 · 13 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 17, 2019 · D · $11,024,999 sold of $28,010,000 · 10 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 8, 2016 · D · $4,163,999 sold of $5,164,000 · 14 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $12.6M from 16 investors (100% of the $5M target) as of the latest filing. Christy is listed as director on 5 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

HO
Pooled Investment Fund · group: Hatteras Venture

Hatteras Opportunity Fund I, LP

Durham, NC · Feb 3, 2023 → Mar 7, 2024 · 2 filings
  • Mar 7, 2024 · D/A · $26,039,738 sold of $125,000,000 · 31 investors · min. No minimum reported · role: Executive Officer (Manager of General Partner) EDGAR ↗
  • Feb 3, 2023 · D · $15,200,000 sold of $125,000,000 · 21 investors · min. No minimum reported · role: Executive Officer (Manager of General Partner) EDGAR ↗

Raised $26M from 31 investors (21% of the $125M target) as of the latest filing. Christy is listed as executive officer on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

HV
Pooled Investment Fund · group: Hatteras Venture

Hatteras Venture Partners VII, LP

Durham, NC · Feb 2, 2023 → Sep 8, 2023 · 2 filings
  • Sep 8, 2023 · D/A · $135,050,000 sold of $250,000,000 · 88 investors · min. No minimum reported · role: Executive Officer (Manager of General Partner) EDGAR ↗
  • Feb 2, 2023 · D · $126,800,000 sold of $250,000,000 · 83 investors · min. No minimum reported · role: Executive Officer (Manager of General Partner) EDGAR ↗

Raised $135.1M from 88 investors (54% of the $250M target) as of the latest filing. Christy is listed as executive officer on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

PT
Biotechnology

PIPr Therapeutics, Inc.

Durham, NC · Mar 8, 2019 → Jun 15, 2022 · 4 filings
  • Jun 15, 2022 · D/A · $18,877,921 sold of $18,877,921 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 23, 2020 · D · $10,877,922 sold of $10,877,922 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 4, 2020 · D · $1,738,391 sold of $2,000,000 · 4 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 8, 2019 · D · $5,000,000 sold of $5,000,000 · 6 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $18.9M from 7 investors (100% of the $18.9M target) as of the latest filing. Christy is listed as director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

HV
Pooled Investment Fund · group: Hatteras Venture

Hatteras Venture Partners VI, LP

Durham, NC · Apr 15, 2019 → Oct 15, 2020 · 2 filings
  • Oct 15, 2020 · D/A · $137,297,065 sold of $250,000,000 · 64 investors · min. No minimum reported · role: Executive Officer (Manager of General Partner of Issuer) EDGAR ↗
  • Apr 15, 2019 · D · $86,300,000 sold of $250,000,000 · 45 investors · min. No minimum reported · role: Executive Officer (Manager of General Partner of Issuer) EDGAR ↗

Raised $137.3M from 64 investors (55% of the $250M target) as of the latest filing. Christy is listed as executive officer on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

PT
Biotechnology

Perfuse Therapeutics, Inc.

San Francisco, CA · Apr 4, 2019 → Jul 29, 2020 · 2 filings
  • Jul 29, 2020 · D · $8,999,991 sold of $38,999,964 · 8 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 4, 2019 · D · $2,000,000 sold of $4,000,000 · 6 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $9M from 8 investors (23% of the $39M target) as of the latest filing. Christy is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CB
Pharmaceuticals

Clearside Biomedical, Inc.

Alpharetta, Georgia (as filed: 2Q) · Jan 9, 2012 → Dec 4, 2019 · 7 filings
  • Dec 4, 2019 · D · $3,349,999 sold of $3,349,999 · 3 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 8, 2015 · D · $14,449,993 sold of $20,000,000 · 9 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 15, 2014 · D · $16,211,809 sold of $20,000,000 · 31 investors · min. $50,000 · role: Director, Promoter EDGAR ↗
  • May 12, 2014 · D · $2,999,997 sold of $6,000,000 · 13 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 12, 2013 · D · $7,899,987 sold of $8,500,000 · 13 investors · min. $50,000 · role: Director EDGAR ↗
  • Feb 16, 2012 · D/A · $3,233,777 sold of $4,000,000 · 7 investors · min. $37,499 · role: Director EDGAR ↗
  • Jan 9, 2012 · D · $1,200,692 sold of $4,000,000 · 4 investors · min. $50,000 · role: Director EDGAR ↗

Raised $16.2M from 31 investors (100% of the $3.35M target) as of the latest filing. Christy is listed as director, promoter on 7 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

SB
Biotechnology

Spyryx Biosciences, Inc.

Durham, NC · May 8, 2015 → Oct 4, 2018 · 3 filings
  • Oct 4, 2018 · D · $5,929,941 sold of $6,000,000 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 12, 2017 · D · $5,000,000 sold of $5,000,000 · 13 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 8, 2015 · D · $18,172,004 sold of $18,172,004 · 13 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $18.2M from 13 investors (100% of the $6M target) as of the latest filing. Christy is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

C
Biotechnology · group: Valence

CalciMedica, Inc.

La Jolla, CA · Dec 21, 2015 → Jun 13, 2018 · 4 filings
  • Jun 13, 2018 · D/A · $75,393,829 sold of $80,393,829 · 16 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 18, 2017 · D/A · $32,943,696 sold of $45,393,828 · 16 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 13, 2016 · D · $20,943,699 sold of $45,393,828 · 15 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 21, 2015 · D · $750,000 sold of $1,000,000 · 1 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $75.4M from 55 investors (94% of the $80.4M target) as of the latest filing. Christy is listed as director, executive officer on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

GT
Biotechnology

G1 Therapeutics, Inc.

Research Triangle Park, NC · Apr 18, 2013 → Jul 1, 2016 · 7 filings
  • Jul 1, 2016 · D/A · $50,000,000 sold of $50,000,000 · 21 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 11, 2016 · D · $46,999,999 sold of $50,000,000 · 20 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 12, 2015 · D · $16,511,994 sold of $33,011,989 · 10 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 23, 2014 · D/A · $12,597,221 sold of $12,597,221 · 8 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 17, 2013 · D · $6,308,145 sold of $12,597,221 · 8 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 23, 2013 · D/A · $1,249,996 sold of $1,250,000 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 18, 2013 · D · $457,902 sold of $1,000,000 · 5 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $50M from 21 investors (100% of the $50M target) as of the latest filing. Christy is listed as director on 7 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

K
Biotechnology · group: Hatteras Venture

KinoDyn, Inc.

Durham, NC · Jun 19, 2014 → Dec 7, 2015 · 2 filings
  • Dec 7, 2015 · D · $349,999 sold of $349,999 · 2 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 19, 2014 · D · $550,000 sold of $550,000 · 2 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $550K from 2 investors (100% of the $350K target) as of the latest filing. Christy is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

HV
Pooled Investment Fund · group: Hatteras Venture

Hatteras Venture Partners V, LP

Durham, NC · Aug 24, 2015
  • Aug 24, 2015 · D · $91,122,449 sold of $150,000,000 · 34 investors · min. No minimum reported · role: Executive Officer (Manager of General Partner) EDGAR ↗

Raised $91.1M from 34 investors (61% of the $150M target) as of the latest filing. Christy is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

E
Other Technology

EVOAPP, INC.

Durham, NC · Feb 11, 2011 → Apr 20, 2012 · 3 filings
  • Apr 20, 2012 · D/A · $1,352,194 sold of $1,352,194 · 32 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 16, 2011 · D · $587,189 sold of $587,189 · 22 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 11, 2011 · D · $1,100,000 sold of $1,500,000 · 13 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $1.35M from 32 investors (100% of the $1.35M target) as of the latest filing. Christy is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

C
Other Health Care

Clinipace Inc

Morrisville, NC · Nov 23, 2009 → May 10, 2011 · 3 filings
  • May 10, 2011 · D · $4,800,000 sold of $5,000,000 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 9, 2011 · D · $3,354,589 sold of $3,354,589 · 3 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 23, 2009 · D · $0 sold of Indefinite · 2 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $17.5M from 16 investors (100% of the $5M target) as of the latest filing. Christy is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

People around Christy 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

HV
Management entity

Hatteras Venture Advisors VII, LLC

Executive Officer, Director · 4 shared filings (2 issuers)

Listed on the same filings as Christy Shaffer. Their page shows their other deals.

HV
Management entity

Hatteras Venture Advisors VI, LLC

Executive Officer, Director · 2 shared filings (2 issuers)

Listed on the same filings as Christy Shaffer. Their page shows their other deals.

HV
Management entity

Hatteras Venture Advisors V, LLC

Executive Officer, Director · 1 shared filing (1 issuer)

Listed on the same filings as Christy Shaffer. Their page shows their other deals.

HV
Management entity

Hatteras Venture Advisors VIII, LLC

Executive Officer, Director · 1 shared filing (1 issuer)

Listed on the same filings as Christy Shaffer. Their page shows their other deals.

CT
Person

Clay Thorp

Director, Executive Officer · 21 shared filings (9 issuers) · also on 10 other issuers

Clay Thorp is on 19 issuers in total — a repeat sponsor. Their page lists every one.

JC
Person

John Crumpler

Director, Executive Officer · 13 shared filings (8 issuers) · also on 8 other issuers

John Crumpler is on 16 issuers in total — a repeat sponsor. Their page lists every one.

DR
Person

Douglas Reed

Executive Officer · 10 shared filings (7 issuers) · also on 10 other issuers

Douglas Reed is on 17 issuers in total — a repeat sponsor. Their page lists every one.

MD
Person

Michael Dial

Executive Officer · 8 shared filings (5 issuers) · also on 3 other issuers

Michael Dial is on 8 issuers in total — a repeat sponsor. Their page lists every one.

GC
Person

Gerald Cagle

Director · 6 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Christy Shaffer. Their page shows their other deals.

DW
Person

Daniel H. White

Executive Officer, Director, Promoter · 6 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Christy Shaffer. Their page shows their other deals.

TS
Person

Tim Shannon

Director · 6 shared filings (2 issuers)

Listed on the same filings as Christy Shaffer. Their page shows their other deals.

JT
Person

Jeffrey Terrell

Executive Officer · 6 shared filings (3 issuers)

Listed on the same filings as Christy Shaffer. Their page shows their other deals.

RI
Person

Robert A. Ingram

Executive Officer · 5 shared filings (4 issuers) · also on 5 other issuers

Robert A. Ingram is on 9 issuers in total — a repeat sponsor. Their page lists every one.

MP
Person

Mark Prausnitz

Director, Promoter · 5 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Christy Shaffer. Their page shows their other deals.

CW
Person

Carol Webb

Director · 5 shared filings (1 issuer)

Listed on the same filings as Christy Shaffer. Their page shows their other deals.

NS
Person

Norman Sharpless

Director · 5 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Christy Shaffer. Their page shows their other deals.

WH
Person

William Humphries

Director · 5 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Christy Shaffer. Their page shows their other deals.

JC
Person

Jeffrey Cleland

Executive Officer, Director · 4 shared filings (1 issuer) · also on 5 other issuers

Jeffrey Cleland is on 6 issuers in total — a repeat sponsor. Their page lists every one.

SR
Person

Seth Rudnick

Director · 4 shared filings (1 issuer) · also on 5 other issuers

Seth Rudnick is on 6 issuers in total — a repeat sponsor. Their page lists every one.

JH
Person

Justin Hanes

Director · 4 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Christy Shaffer. Their page shows their other deals.

TL
Person

Thomas K Laundon

Executive Officer · 4 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Christy Shaffer. Their page shows their other deals.

CD
Person

Charles A. Deignan

Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as Christy Shaffer. Their page shows their other deals.

JS
Person

Jay Strum

Executive Officer, Director · 4 shared filings (1 issuer)

Listed on the same filings as Christy Shaffer. Their page shows their other deals.

RL
Person

Ron Laufer

Director · 4 shared filings (1 issuer)

Listed on the same filings as Christy Shaffer. Their page shows their other deals.

MV
Person

Mark A. Velleca

Executive Officer, Director · 4 shared filings (1 issuer)

Listed on the same filings as Christy Shaffer. Their page shows their other deals.

SN
Person

Schalon Newton

Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as Christy Shaffer. Their page shows their other deals.

DE
Person

David Eveleth

Executive Officer, Director · 4 shared filings (1 issuer)

Listed on the same filings as Christy Shaffer. Their page shows their other deals.

HT
Person

Holden Thorp

Director · 4 shared filings (1 issuer)

Listed on the same filings as Christy Shaffer. Their page shows their other deals.

SR
Person

Stella Robertson

Director · 4 shared filings (1 issuer)

Listed on the same filings as Christy Shaffer. Their page shows their other deals.

BM
Person

Ben McGraw

Director · 4 shared filings (1 issuer)

Listed on the same filings as Christy Shaffer. Their page shows their other deals.

JM
Person

Jeremy Mario

Director · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Christy Shaffer. Their page shows their other deals.

RW
Person

Rick Widin

Director · 3 shared filings (1 issuer)

Listed on the same filings as Christy Shaffer. Their page shows their other deals.

JW
Person

Jeff L. Williams

Executive Officer, Director · 3 shared filings (1 issuer)

Listed on the same filings as Christy Shaffer. Their page shows their other deals.

CP
Person

Christopher K. Porter

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Christy Shaffer. Their page shows their other deals.

RB
Person

Robert Bicksler

Director · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Christy Shaffer. Their page shows their other deals.

JS
Person

Jonathan Soderstrom

Director · 3 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Christy Shaffer. Their page shows their other deals.

MF
Person

Marco Fregenal

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Christy Shaffer. Their page shows their other deals.

JD
Person

Joseph Patrick Davy

Executive Officer, Director · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Christy Shaffer. Their page shows their other deals.

JM
Person

J. Thomas McMurray

Director · 3 shared filings (1 issuer)

Listed on the same filings as Christy Shaffer. Their page shows their other deals.

The team behind the deals

HV
Sponsor group

Hatteras Venture

9 issuers · 14 filings · $512.7M reported sold · 2011–2026

One team, 9 deal companies. Christy Shaffer is listed on 8 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Christy Shaffer.

V
Sponsor group

Valence

5 issuers · 25 filings · $90.8M reported sold · 2009–2023

One team, 5 deal companies. Christy Shaffer is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Christy Shaffer.

Same business address

28 other issuers file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Adviser registration (Form ADV)

Not yet searched. Sources to be searched: SEC Investment Adviser Information Reports — Form ADV data for SEC-registered advisers and exempt reporting advisers (file dated 2026-10-02); SEC Investment Adviser Public Disclosure (IAPD) firm search — registered and exempt reporting advisers · Search queued. Results are added automatically; check back later.

Other offering types (Regulation A and Regulation Crowdfunding)

None found in sources searched.

Sources searched: SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 · Last checked Oct 23, 2026, 8:41 PM ET.

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Durham, NC). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗North Carolina eCourts portal ↗Maryland Judiciary case search ↗California — find the county court ↗Los Angeles Superior Court case search ↗Georgia state courts — find the court ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

North Carolina Secretary of State business search ↗Maryland Secretary of State business search ↗California Secretary of State business search ↗Georgia Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Christy Shaffer appears on a new Form D, or when a court case or SEC action is matched to them. See plans →